RenovoRx Income Statement (2024-2025) | RNXT

Income Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.20M0.42M0.27M0.24M
Gross Profit (Quarter) 0.10M0.27M0.21M0.21M
Operating items
Research & Development (Quarter) 1.26M1.54M1.65M1.58M1.64M1.43M1.69M1.50M
Selling, General & Administrative (Quarter) 1.22M1.49M1.18M1.10M1.57M1.52M1.73M2.23M
Operating Expenses (Quarter) 2.48M3.03M2.83M2.67M3.21M2.95M3.41M3.73M
Operating Income (Quarter) -2.48M-3.03M-2.83M-2.63M-3.11M-2.68M-3.20M-3.52M
EBIT (Quarter) -2.48M-3.03M-2.83M-2.63M-3.11M-2.68M-3.20M-3.52M
Non-operating items
Interest & Investment Income (Quarter) 0.04M0.14M0.12M0.09M0.11M0.13M0.11M0.07M
Non Operating Income (Quarter) 1.40M0.65M0.36M-0.25M0.69M-0.22M0.29M0.58M
Net income details
EBT (Quarter) -2.44M-2.90M-2.70M-2.55M-3.00M-2.54M-3.09M-3.45M
Profit After Tax (Quarter) -1.08M-2.39M-2.47M-2.55M-2.42M-2.90M-2.91M-3.45M
Income from Continuing Operations (Quarter) -2.44M-2.90M-2.70M-2.55M-3.00M-2.54M-3.09M-3.45M
Consolidated Net Income (Quarter) -2.44M-2.90M-2.70M-2.55M-3.00M-2.54M-3.09M-3.45M
Income towards Parent Company (Quarter) -2.44M-2.90M-2.70M-2.55M-3.00M-2.54M-3.09M-3.45M
Net Income towards Common Stockholders (Quarter) -2.44M-2.90M-2.70M-2.55M-3.00M-2.54M-3.09M-3.45M
Additional items
EPS (Basic) (Quarter) -0.07-0.10-0.10-0.12-0.08-0.08-0.08-0.08
EPS (Weighted Average and Diluted) (Quarter) -0.07-0.10-0.10-0.12-0.08-0.08-0.08-0.08
Shares Outstanding (Weighted Average) (Quarter) 14.95M24.05M21.33M22.27M31.40M36.58M34.89M35.33M
Shares Outstanding (Diluted Average) (Quarter) 14.95M24.05M24.94M22.27M31.40M34.00M36.65M35.33M
EBITDA (Quarter) -2.48M-2.39M-2.83M-2.63M-3.11M-2.68M-3.20M-3.52M
Shares Outstanding (Quarter) 16.87M23.97M24.00M24.03M36.55M36.65M36.65M36.61M